000 | 01659nam a22002417a 4500 | ||
---|---|---|---|
003 | MX-MxAU | ||
005 | 20190708110250.0 | ||
008 | 190705b2002 mx ||||| |||| 00| 0 spa | ||
020 | _a9706402098 (Obra completa) | ||
020 | _a9706402101 (Vol. I) | ||
020 | _a(Vol. II) | ||
020 | _a(Vol. III) | ||
040 |
_aMX-MxAU _bMX-MxAU _cMX-MxAU |
||
041 | _aspa | ||
082 |
_a616 _bA321 |
||
100 | 1 | _aAlarcón Segovia, Donato | |
245 |
_aObras 1 : _bdescripciones clínicas / _cDonato Alarcón Segovia |
||
260 |
_aMéxico : _bEl Colegio Nacional, _c2002. |
||
300 |
_a515 p. ; _c24 x 16 cm. |
||
500 | _aIncluye índice | ||
505 | _a1. Descripciones clínicas -- 2. Manifestaciones viscerales del lupus eritematoso diseminado -- 3. Pleuro-pulmonary manifestationes of systemic lupus erythematosus -- 4. Case report: Erythermalgia in systemic lupues erythematosus -- 5. Systemic lupues erytheatosus following thymectomy for myasthenia gravis -- 6. Electron microscopy of the lupus erythematosus cell -- 7. Chronic hepatic disease in women with lupus erythematosus cell phenomenon -- 8. Significance of the lupus erythematosus cell phenomenon in older women with chronic hepatic disease -- 9. Peripheralvascular syndrome associated with systemic lupus erythematousus -- 10. Antiphospolipid antibodies and antiphospolipid syndrome in systemic lupus erythematousus. Aprospctive analysis of 500 consecutive patients -- 11. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematousus -- 12. Brief recording. Ulceration and perforation of the nasal septum in systemic lupus erythematosus | ||
942 | _cLB | ||
999 |
_c69173 _d69173 |